Remove Bioinformatics Remove Gene Therapy Remove Production Remove Recombinant Antibody
article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

Thomas Valerius, MD, Professor, Stem Cell Transplantation & Immunotherapy, Christian Albrechts University of Kiel, on: ‘Neutrophil-activating therapy for the treatment of cancer’. Lei Shi, PhD, Senior Vice President, R&D, Biointron Biological, on: ‘Accelerating early discovery through htp and high-speed antibody production’.